Purchase Order 75N93024P00469
Award Date
3/26/24
Potential Completion Date
3/25/25
Potential Value
$16K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions. The $13,250.00 contract is for a MiSeq Silver Support Plan, with a completion date of September 25, 2020. Illumina has previously received prime federal contracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems,...
This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis products, to provide TruSeq and MiSeq sequencing kits. The $10,176.95 award supports the agency's research and diagnostics needs, and follows previous prime contract awards to Illumina under which the company has supplied sequencing systems, reagents, and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of NextSeq, MiSeq, and iSeq sequencing kits. The $96,390.00 award does not have a set-aside designation and is intended to support genomic research and analysis at the agency's Bethesda, MD location. Illumina has...
This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for MISSEQ, CBOT2 AND HISEQ 4000 BRONZE AND SILVER MAINTENANCE PLANS. The $124,639.96 contract does not have a set-aside designation. Illumina has previously been awarded federal contracts by agencies such as the NIH, CDC, USDA, and VA...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $242,052.50 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for consumables to support Illumina's MiSeq sequencing instrument. No set-aside provisions were applied to this award. Illumina will provide sequencing consumables and supplies for the MiSeq platform to support genomic research efforts of the...